No data to show
XWAR
HRP
Market cap10mUSD
Jul 30, Last price
6.10PLN
1D
-2.87%
1Q
25.77%
Jan 2017
-33.70%
IPO
-87.27%
Name
Harper Hygienics SA
Chart & Performance
P/E
14.19
P/S
0.14
EPS
0.43
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
2.57%
Revenues
268m
-2.31%
Net income
3m
+526.23%
CFO
12m
+236.65%
Profile
Harper Hygienics S.A. produces and sells cosmetic hygienic skin care products for women, infants, and children in Poland and internationally. The company offers cotton buds, make up removal pads, make up removal wipes, cosmetic buds, refreshing and baby wipes, refreshing wet wipes for hands and body, and intimate hygiene wipes; disposable wet wipes, cosmetic pads, and hygienic buds; wipes for surfaces, such as kitchen, bathroom, windows and mirrors, wooden furniture, anti-electrostatic, and leather furniture; and nail varnish removal pads, as well as cotton pads and wet tissues. It offers its products under the Sweet Sense, Cleanic, Cleanic Kindii, Presto Clean, Nieznost, and Ola brand names, as well as under private labels for retail chains. Harper Hygienics S.A. was founded in 1990 and is based in Warsaw, Poland.
Valuation
Title PLN in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | 268,399 3.10% | 274,756 5.54% | ||||||||
Cost of revenue | 256,333 | 267,367 | ||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 12,066 | 7,389 | ||||||||
NOPBT Margin | 4.50% | 2.69% | ||||||||
Operating Taxes | 1,506 | 491 | ||||||||
Tax Rate | 12.48% | 6.64% | ||||||||
NOPAT | 10,560 | 6,898 | ||||||||
Net income | 2,738 -127.15% | 437 -104.34% | ||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | 25,537 | 30,915 | ||||||||
Long-term debt | 81,638 | 77,425 | ||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 28,786 | 24,599 | ||||||||
Net debt | 106,536 | 107,709 | ||||||||
| Cash flow | ||||||||||
Cash from operating activities | 11,810 | 3,508 | ||||||||
CAPEX | (2,035) | (1,871) | ||||||||
Cash from investing activities | (1,742) | (1,787) | ||||||||
Cash from financing activities | (10,132) | (1,842) | ||||||||
FCF | 62,877 | 62,415 | ||||||||
| Balance | ||||||||||
Cash | 412 | 404 | ||||||||
Long term investments | 227 | 227 | ||||||||
Excess cash | ||||||||||
Stockholders' equity | 61,285 | 56,960 | ||||||||
Invested Capital | 193,606 | 186,485 | ||||||||
ROIC | 5.62% | 3.74% | ||||||||
ROCE | 6.23% | 3.96% | ||||||||
| EV | ||||||||||
Common stock shares outstanding | 6,367 | 6,367 | ||||||||
Price | 7.08 1.14% | 4.93 -29.64% | ||||||||
Market cap | 45,078 1.14% | 31,357 -29.64% | ||||||||
EV | 151,615 | 139,067 | ||||||||
EBITDA | 20,727 | 15,993 | ||||||||
EV/EBITDA | 7.31 | 8.70 | ||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||